Purchases and Sales Made in Q3 2022 in Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT) during Q3 2022. The information is specifically focused on institutions that hold shares of Calliditas Therapeutics AB.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Hbk Sorce Advisory LLC
Erie, PA |
BUY
|
- |
45KNew |
$635K - $1.01M
|
45K
$1.8M
|
|
Nov 14, 2022
Q3 2022
|
Optiver Holding B.V.
Amsterdam, P7 |
BUY
|
- |
11.7K+ 1304.34% |
$166K - $264K
|
12.6K
$505K
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.11K+ 1270.2% |
$43.9K - $70K
|
3.36K
$134K
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
886+ 7.63% |
$12.5K - $19.9K
|
12.5K
$500K
|
|
Nov 08, 2022
Q3 2022
|
Ifp Advisors, Inc
|
BUY
|
- |
350New |
$4.94K - $7.87K
|
350
$14K
|
|
Nov 04, 2022
Q3 2022
|
Simplex Trading, LLC
|
BUY
|
- |
289+ 28900.0% |
$4.08K - $6.5K
|
290
$11.6K
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Ironwood Investment Management LLC
Boston, MA |
SELL
|
- |
-21- 0.07% |
$297 - $472
|
28.7K
$1.15M
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-82- 18.1% |
$1.16K - $1.84K
|
371
$14.8K
|
|
Oct 25, 2022
Q3 2022
|
Cutler Group LP
|
SELL
|
- |
-340- 60.71% |
$4.8K - $7.65K
|
220
$8.8K
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-377- 59.28% |
$5.32K - $8.48K
|
259
$10.4K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3.16K- 73.62% |
$44.6K - $71.1K
|
1.13K
$45.3K
|